ArticleAmerican journal of hematology2025

Efficacy and Thrombotic Risk of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia Secondary to Systemic Lupus and Antiphospholipid Syndrome: French Experience With 80 Patients.

Cindy Marques et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.